Nanobots Therapeutics successfully closes a Pre-Seed funding round of €478,000
The start-up specializes in the development of biocompatible nanorobots capable of delivering drugs to difficult-to-treat tumors more efficiently and safely than current therapies. Nanobots Therapeutics is the third investment in the fifth edition of Banco Sabadell’s BStartup Health program, which received applications from 127 start-ups. The pre-seed funding round of the start-up Nanobots Therapeutics is … Read more
